KT-333 is under clinical development by Kymera Therapeutics and currently in Phase I for Head And Neck Cancer. According to GlobalData, Phase I drugs for Head And Neck Cancer have a 75% phase ...

Another year is drawing to a close, with another strain of the coronavirus making the rounds. But this time, medical professionals say it might be harder to distinguish whether you have COVID-19 ...

More specifically, real-time transborder surveillance of this emerging highly drug-resistant AFR13 7PET strain is needed because the potential acquisition of an additional tetracycline-resistance ...

Paris - Here are the list of the countries that announced a ban on flights and travellers from the UK in the wake of a new coronavirus strain. Countries around the world have begun banning flights ...